Nervgen PharmaNGEN
13F holders, Q4 2025 (December 31)1holders
0new positions
0sold out
$5.60avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Nervgen Pharma Corp. (NGEN) in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holder was Paladin Partners, LLC ($56K).
- Company
- Nervgen Pharma Corp.
- CUSIP
- 64082X203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Paladin Partners, LLC | 0.04% | — | 10,000 | $56K |
"% of holder's portfolio" is NGEN's weight in each manager's 13F, not the share of Nervgen Pharma Corp. the manager owns.